The Potential Mechanism of Cannabidiol (CBD) Treatment of Epilepsy in Pentetrazol (PTZ) Kindling Mice Uncovered by Multi-Omics Analysis
Open Access
Abstract
Cannabidiol (CBD) is the main active ingredient in the cannabis plant used for treating epilepsy and related diseases. However, how CBD ameliorates epilepsy and its effect on the hippocampus remains unknown. Herein, we evaluated how CBD ameliorates seizure degree in pentylenetetrazol (PTZ) induced epilepsy mice after being exposed to CBD (10 mg/kg p.o). In addition, transcriptome and metabolomic analysis were performed on the hippocampus. Our results suggested that CBD could alleviate PTZ-induced seizure, of which the NPTX2, Gprc5c, Lipg, and Stc2 genes were significantly down-regulated in mice after being exposed to PTZ. Transcriptome analysis showed 97 differently expressed genes (CBD) and the PTZ groups. Metabonomic analysis revealed that compared with the PTZ group, 41 up-regulated and 67 down-regulated metabolites were identified in the hippocampus of epileptic mice exposed to CBD. The correlation analysis for transcriptome and metabolome showed that (±) 15-HETE and carnitine C6:0 were at the core of the network and were involved in the positive or negative regulation of the related genes after being treated with CBD. In conclusion, CBD ameliorates epilepsy by acting on the metabolism, calcium signaling pathway, and tuberculosis pathways in the hippocampus. Our study provided a practical basis for the therapeutic potential of treating epilepsy using CBD.Keywords
Funding Information
- Program for Shenyang High Level Talent Innovation and Entrepreneurship Team (2019-SYRCCY-B-01, 20-204-4-22)
- Shenyang S&T Projects (2019-SYRCCY-B-01, 20-204-4-22)
This publication has 37 references indexed in Scilit:
- Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in BrainJournal of Biological Chemistry, 2012
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+LevelsThe Journal of Neuroscience, 2009
- Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short reviewPharmacology Biochemistry and Behavior, 2008
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- Role of the Go/i signaling network in the regulation of neurite outgrowthThis paper is one of a selection of papers published in this Special issue, entitled Second Messengers and Phosphoproteins—12th International Conference.Canadian Journal of Physiology and Pharmacology, 2006
- Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cellsNeuropharmacology, 2006
- Plasma urea and ammonia in epileptic patients and their relativesEpilepsy Research, 1992
- Enhancement of cyclic AMP-dependent sodium current by the convulsant drug pentylenetetrazolBrain Research, 1988
- Evidence for involvement of the astrocytic benzodiazepine receptor in the mechanism of action of convulsant and anticonvulsant drugsLife Sciences, 1988
- HYPERURICÆMIC ACUTE RENAL FAILURE AFTER EPILEPTIC SEIZURESThe Lancet, 1975